Dr. Russell Blaylock, author of The Blaylock Wellness Report newsletter, is a nationally recognized board-certified neurosurgeon, health practitioner, author, and lecturer. He attended the Louisiana State University School of Medicine and completed his internship and neurological residency at the Medical University of South Carolina. For 26 years, practiced neurosurgery in addition to having a nutritional practice. He recently retired from his neurosurgical duties to devote his full attention to nutritional research. Dr. Blaylock has authored four books, Excitotoxins: The Taste That Kills, Health and Nutrition Secrets That Can Save Your Life, Natural Strategies for Cancer Patients, and his most recent work, Cellular and Molecular Biology of Autism Spectrum Disorders. Find out what others are saying about Dr. Blaylock by clicking here.
Tags: cancer | inflammation | synergy | multidrug resistance

Synergy in Cancer Treatment

Tuesday, 14 August 2018 04:05 PM Current | Bio | Archive

Cancer is a very complex, multifaceted disease that is strongly associated with inflammation.

Many studies have shown that reducing inflammation reduces cancer risk, and can also reduce the spread and growth of existing cancers.

We know that inhibiting cancer requires blocking a number of cell-signaling mechanisms, as well boosting immunity and stopping mechanisms that enhance tumor invasion and spread.

Unlike chemotherapy agents, which do not differentiate between normal cells and cancer cells, anticancer compounds found in medicinal plants selectively target cancer cells.

In doing so, they not only spare damage to normal cells, they also protect normal cells from damage by chemotherapy agents and radiation.

The basis of this protection is the difference in metabolism between cancer cells and normal cells.

Most chemotherapy agents act on one of two mechanisms, which the cancer cell can quickly adapt to.

One way cancer cells avoid damage from chemotherapy agents is to use cell mechanisms to expel the chemotherapy agent, thus preventing damage to the cancer cell.

Once a cancer cell develops resistance to one chemotherapy drug, it is usually resistant to most of them — a process called multidrug resistance (MDR).

Another method of protection cancer cells use is to shut off special suicide genes (p53 and p21 genes) by mutating them. These genes exist in all cells, and are activated when a cell is badly damaged and at a high risk of becoming a cancer cell.

When the cell is killed, it cannot convert into cancer. But when the suicide genes are turned off, the cell becomes immortal, and cancerous.

A number of plant extracts can repair the cells’ suicide genes, and thus kill tumor cells.

Plant extracts can also reverse multidrug resistance, making the cancer cell vulnerable once again to chemotherapy drugs and other treatments.

Plant extracts can also make cancer cells selectively hypersensitive to being killed by radiation treatments, and at the same time protect surrounding normal cells from radiation damage.

Curcumin is particularly effective at this type of dual effect.

© 2019 NewsmaxHealth. All rights reserved.

1Like our page
We know that inhibiting cancer requires blocking a number of cell-signaling mechanisms, as well boosting immunity and stopping mechanisms that enhance tumor invasion and spread.
cancer, inflammation, synergy, multidrug resistance
Tuesday, 14 August 2018 04:05 PM
Newsmax Media, Inc.

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved